# EDGAR Filing Document

**Accession Number:** 0001476840
**File Stem:** 0001476840-23-000021
**Filing Date:** 2023-2
**Character Count:** 43549
**Document Hash:** 0e8eb38e4d7d2428c53355cb5c3d10a0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001476840-23-000021.hdr.sgml**: 20230223

**ACCESSION NUMBER**: 0001476840-23-000021

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 42

**CONFORMED PERIOD OF REPORT**: 20230223

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230223

**DATE AS OF CHANGE**: 20230223

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Expensify, Inc.
- **CENTRAL INDEX KEY:** 0001476840
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **IRS NUMBER:** 270239450
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41043
- **FILM NUMBER:** 23659782

**BUSINESS ADDRESS:**
- **STREET 1:** 401 SW 5TH AVENUE
- **CITY:** PORTLAND
- **STATE:** OR
- **ZIP:** 97204
- **BUSINESS PHONE:** (520) 271-0858

**MAIL ADDRESS:**
- **STREET 1:** 401 SW 5TH AVENUE
- **CITY:** PORTLAND
- **STATE:** OR
- **ZIP:** 97204

?xml version="1.0" ? exfy-20230223

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 8-K**

**CURRENT REPORT** 

**PURSUANT TO SECTION 13 OR 15(d)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of report (Date of earliest event reported): February 23, 2023**

**Expensify, Inc.** 

**(Exact Name of Registrant as Specified in its Charter)** 

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41043** | **27-0239450** |
| **(State or Other Jurisdiction**<br>**of Incorporation)** | **(Commission**<br>**File Number)** | **(IRS Employer**<br>**Identification No.)** |

---

**401 SW 5**<sup>th</sup> **Ave**

**Portland, Oregon 97204** 

**(Address of Principal Executive Offices) (Zip Code)**

**(971) 365-3939** 

**(Registrant's telephone number, including area code)**

**Not applicable** 

**(Former Name or Former Address, if Changed Since Last Report)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbols** | **Name of each exchange**<br>**on which registered** |
| **Class A Common Stock, par value $0.0001 per share** | **EXFY** | **The Nasdaq Stock Market LLC** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition.**

On February 23, 2023, Expensify, Inc. ("Expensify" or the "Company") issued a press release announcing its financial results for the year and quarter ended December 31, 2022. A copy of this press release is furnished as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.

**Item 7.01 Regulation FD Disclosure.**

On February 23, 2023, the Company posted an investor presentation to its website at https://ir.expensify.com (the "Investor Presentation"). A copy of the Investor Presentation is attached as Exhibit 99.2 to this current report on Form 8-K and is incorporated herein by reference. The Company expects to use the Investor Presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others.

The information contained in the Investor Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission ("SEC") filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Investor Presentation speaks only as of the date of this current report on Form 8-K. The Company undertakes no duty or obligation to publicly update or revise the information included in the Investor Presentation, although it may do so from time to time. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or other public disclosure. In addition, the exhibit furnished herewith contains statements intended as "forward-looking statements" that are subject to the cautionary statements about forward-looking statements set forth in such exhibit. By furnishing the information contained in the Investor Presentation, the Company makes no admission as to the materiality of any information in the Investor Presentation that is required to be disclosed solely by reason of Regulation FD.

The information contained in Item 2.02 and this Item 7.01, including Exhibit 99.1 and 99.2, is being furnished and shall not be deemed "filed" for the purposed of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by Expensify under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

**Item 9.01 Financial Statements and Exhibits.** 

(d) <u>Exhibits</u>.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | <u>[Press Release issued by Expensify, Inc., dated](exhibit991-8xkq422earnings.htm)[February](exhibit991-8xkq422earnings.htm)[23](exhibit991-8xkq422earnings.htm)[, 202](exhibit991-8xkq422earnings.htm)[3](exhibit991-8xkq422earnings.htm)[.](exhibit991-8xkq422earnings.htm)</u> |
| 99.2 | <u>[Investor Presentation, dated](exhibit992-8xkq422investor.htm)[February](exhibit992-8xkq422investor.htm)[2](exhibit992-8xkq422investor.htm)[3](exhibit992-8xkq422investor.htm)[, 202](exhibit992-8xkq422investor.htm)[3](exhibit992-8xkq422investor.htm)[.](exhibit992-8xkq422investor.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**<u>SIGNATURE</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| Expensify, Inc. | Expensify, Inc. |
| By: | /s/ Ryan Schaffer |
| Name: | Ryan Schaffer |
| Title: | Chief Financial Officer |

---

Date: February 23, 2023

## Exhibit 99.1

**Exhibit 99.1**

**EXPENSIFY ANNOUNCES Q4 AND FULL YEAR FISCAL 2022 RESULTS**

*The company demonstrated strong positive operating cash flow of $32.9 million on $169.5 million in revenue, a revenue increase of 19% compared to the same period last year.* 

PORTLAND, Ore.--(BUSINESS WIRE)--February 23, 2023-- Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards and bills, today announced results for its quarter and year ended December 31, 2022.

"We had a great year considering the challenging macroeconomic environment. The business continues to grow across multiple areas, despite volatility affecting all businesses but especially SMBs. We are heads down executing our long-term product roadmap, and could not be more excited about what we have in store. Pending an eventual return to normalcy, we remain confident with our long-term growth guidance." said David Barrett, Founder & CEO of Expensify. "I continue to contribute 100% of my salary to the employee stock purchase program and the company has been buying back company stock, so we remain very bullish on the future."

"This year proved Expensify is a very strong business able to generate positive cash flow in extremely challenging environments," said Ryan Schaffer, Expensify's CFO. "We had an operating cash flow margin of 19% and a free cash flow margin of 15%. We are proud to have repurchased $12.1 million in common stock, including net share settlement of equity awards, in 2022 and plan to keep generating positive cash flow and repurchasing in 2023. Needless to say, we feel we are in a strong position and remain excited for the future."

**<u>Financial:</u>**

**Full Year Fiscal 2022 Highlights** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue was $169.5 million, an increase of 19% compared to the same period last year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Generated $32.9 million cash provided by operating activities and $26.3 million of free cash flow.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net loss was $27.0 million, compared to $13.6 million for the same period last year. This was heavily driven by stock-based compensation expenses of $52.3 million which is expected to decrease in the future. (See stock-based compensation forecast below.)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP net income was $25.3 million.&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA was $42.5 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interchange derived from the Expensify Card grew to $6.8 million, an increase of 118% compared to the same period last year.

**Fourth Quarter 2022 Highlights** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue was $43.5 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Generated $6.6 million cash provided by operating activities and $6.0 million of free cash flow.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net loss was $3.4 million, compared to $21.9 million for the same period last year. The loss in Q4 2022 was primarily driven by a stock-based compensation expense of $10.5 million. The loss in Q4 2021 was primarily driven by a stock-based compensation expense of $12.1 million and a one-time IPO-related bonus expense of $14.2 million. Stock-based compensation is expected to decrease going forward. (See stock-based compensation forecast below.)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP net income was $7.1 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA was $11.2 million.

------

**Exhibit 99.1**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interchange derived from the Expensify Card grew to $2.0 million, an increase of 91% compared to the same period last year.

**<u>Business</u>**

**2022 Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Revamped the ExpensifyApproved! channel** - Made significant progress in the accounting channel:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Announced the Expensify CPA card with accountant-specific perks.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Assigned Partner Managers to the 500+ largest partner firms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Announced ExpensiCon 3, bringing together 100 of the the top minds in accounting and featuring headline speaker George Clooney.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Added Account Managers** - Created account management program and rolled out Account Managers to nearly all paying customers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Added onboarding phone support** - All customers being onboarded get a response in two minutes or less.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Built a React Native community** - To continue rapid advancement of new.expensify.com, which is being built by internal Expensify engineers and an external network including some of the world's best React Native engineers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Worked with hundreds of different open source React Native engineers from around the world.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Paid out over a million dollars to the open source engineers to work on the Expensify platform.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Buyback** - As previously announced, the Executive Committee of our Board of Directors approved a share repurchase program with authorization to purchase up to $50.0 million of shares of our Class A common stock. We repurchased $12.1 million of our Class A common stock, including net share settlement of equity awards, in 2022.

**Fourth Quarter 2022 Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Paid members** - Paid members grew to 779,000, an increase of 10% from the same period last year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **ExpensiConX** - Invited hundreds of React Native developers to ExpensiConX, a conference that will bring together some of the top React Native engineers in the world with the goal of building the next great collaborative fintech superapp, all in Curaçao. The event will take place in March 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **New Sales Development Representatives** - Onboarded Sales Development Representatives ("SDRs") across four different vendors. We're in the process of scaling SDRs as we look to increase the amount of leads flowing to our Account Managers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Continuing to scale Account Managers** - More than doubled our Account Manager coverage to nearly all paying customers.

**<u>Financial Outlook</u>**

Expensify's outlook statements are based on current estimates, expectations and assumptions and are not a guarantee of future performance. The following statements are forward-looking and actual results could differ materially depending on market conditions and the factors set forth under "Forward-Looking Statements" below. There can be no assurance that the Company will achieve the results expressed by this guidance.

We reaffirm our long term guidance provided in connection with our fourth quarter 2021 results of 25-35% revenue growth over a multi-year period, which assumes an eventual return to normalcy of the world economy.

------

**Exhibit 99.1**

Expensify is also providing an estimate on what stock based compensation is expected to look like for the next four fiscal quarters. Driven primarily by the pre-IPO grant of RSUs issued to all employees (which vest quarterly over eight years with approximately seven years remaining), stock based compensation is estimated as seen below:

**Est. stock-based compensation (millions)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q1 2023** | **Q1 2023** | **Q2 2023** | **Q2 2023** | **Q3 2023** | **Q3 2023** | **Q4 2023** | **Q4 2023** |
| | **Low** | **High** | **Low** | **High** | **Low** | **High** | **Low** | **High** |
| Cost of revenue, net | $3.6 | $4.3 | $3.4 | $4.2 | $3.4 | $4.1 | $3.3 | $4.0 |
| Research and development | 2.0 | 2.4 | 1.9 | 2.3 | 1.9 | 2.3 | 1.8 | 2.3 |
| General and administrative | 2.4 | 2.9 | 2.3 | 2.8 | 2.3 | 2.8 | 2.2 | 2.7 |
| Sales and marketing | 1.7 | 2.1 | 1.7 | 2.0 | 1.6 | 2.0 | 1.6 | 1.9 |
| Total | $9.7 | $11.7 | $9.3 | $11.3 | $9.2 | $11.2 | $8.9 | $10.9 |

---

**<u>Availability of Information on Expensify's Website</u>**

Investors and others should note that Expensify routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Expensify Investor Relations website at https://ir.expensify.com. While not all of the information that the Company posts to its Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Expensify to review the information that it shares on its Investor Relations website.

**<u>Conference Call</u>**

Expensify will host a video call to discuss the financial results and business highlights at 2:00 p.m. Pacific Time today. An investor presentation and the video call information is available on Expensify's Investor Relations website at https://ir.expensify.com. A replay of the call will be available on the site for three months.

**<u>Non-GAAP Financial Measures</u>**

In addition to financial measures prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), we provide certain non-GAAP financial measures, including adjusted EBITDA, non-GAAP net income, free cash flow and free cash flow margin.

We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.

------

**Exhibit 99.1**

**Adjusted EBITDA.** We define adjusted EBITDA as net income from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization and stock based compensation.

**Non-GAAP net income.** We define non-GAAP net income as net income from operations in accordance with US GAAP excluding stock-based compensation and IPO-related bonus costs. Prior to the fourth quarter of 2021, this metric only excluded IPO-related bonus costs and did not exclude expenses related to stock-based compensation. However, management now believes that further excluding stock-based compensation from non-GAAP net income is useful to better understand the financial performance of our business and to facilitate a better comparison of our results to those of peer companies over multiple periods given that this item may vary between companies for reasons unrelated to overall operating performance. IPO-related bonus costs impacted the second, third and fourth fiscal quarters of 2021 but did not impact any quarters in 2022 and are not expected to impact future periods.

**Non-GAAP net income margin.** We define non-GAAP net income as non-GAAP net income divided by total revenue for the same period.

**Free cash flow.** We define Free cash flow as net cash provided by operating activities excluding changes in settlement assets and settlement liabilities, which represent funds held for customers and customer funds in transit, respectively, reduced by the purchases of property and equipment and software development costs.

**Free cash flow margin.** We define Free cash flow margin as Free cash flow divided by total revenue for the same period.

The tables at the end of the Consolidated Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.

**<u>Forward-Looking Statements</u>**

Forward-looking statements in this press release, or made during the earnings call, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management and expected market growth, our ability to meet our long-term guidance, the amount and timing of any share repurchases, our stock-based compensation estimates and the timing of when we expect the economy to return to normalcy and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "shall," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "goal," "objective," "seeks," "outlook," or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the impact on inflation on us and our members; our borrowing costs have and may continue to increase as a result of increases in interest rates; our expectations regarding our financial performance and future operating performance; our ability to attract and retain members, expand usage of our platform, sell subscriptions to our platform and convert individuals and organizations into paying customers; the timing and success of new features, integrations, capabilities and enhancements by us, or by competitors to their products, or any other changes in the competitive landscape of our market; the amount and timing of operating expenses and capital expenditures that we may incur to maintain and expand our business and operations to remain competitive; the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs; our ability to make required payments under and to comply with the various requirements of our current and future indebtedness; our cash flows, the prevailing stock prices, general economic and market conditions and other considerations that could affect the specific timing, price and size of repurchases under our stock repurchase program or our ability to fund any stock repurchases; the war in Ukraine and escalating geopolitical tensions as a result of Russia's invasion of Ukraine; our ability to effectively manage our exposure to

------

**Exhibit 99.1**

fluctuations in foreign currency exchange rates; the increased expenses associated with being a public company; the size of our addressable markets, market share and market trends; anticipated trends, developments and challenges in our industry, business and the highly competitive markets in which we operate; our expectations regarding our income tax liabilities and the adequacy of our reserves; our ability to effectively manage our growth and expand our infrastructure and maintain our corporate culture; our ability to identify, recruit and retain skilled personnel, including key members of senior management; the safety, affordability and convenience of our platform and our offerings; our ability to successfully defend litigation brought against us; our ability to successfully identify, manage and integrate any existing and potential acquisitions of businesses, talent, technologies or intellectual property; general economic conditions in either domestic or international markets; our protections against security breaches, technical difficulties, or interruptions to our platform; our ability to maintain, protect and enhance our intellectual property; and other risks discussed in our filings with the SEC. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. We caution you not to place undue reliance on any forward-looking statements, which are made only as of the date of this press release. We do not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable law. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

**<u>About Expensify</u>**

Expensify is a payments superapp that helps individuals and businesses around the world simplify the way they manage money. More than 12 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app. All free. Whether you own a small business, manage a team, or close the books for your clients, Expensify makes it easy so you have more time to focus on what really matters.

**Investor Relations Contact**

Nick Tooker

investors@expensify.com

**Press Contact**

James Dean

press@expensify.com

------

**Expensify, Inc.**

**Consolidated Balance Sheets**

(unaudited, in thousands, except share and per share data)

---

| | | |
|:---|:---|:---|
| | **As of December 31,** | **As of December 31,** |
| | **2022** | **2021** |
| **Assets** |  |  |
| Cash and cash equivalents | $103787 | $98398 |
| Accounts receivable, net | 16448 | 15713 |
| Settlement assets, net | 35838 | 21880 |
| Prepaid expenses | 8825 | 7436 |
| Related party loan receivable |  | 14 |
| Other current assets | 22217 | 14201 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 187115 | 157642 |
| Capitalized software, net | 6881 | 6359 |
| Property and equipment, net | 14492 | 15930 |
| Lease right-of-use assets | 745 | 2202 |
| Deferred tax assets, net | 344 | 370 |
| Other assets | 664 | 710 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $210241 | $183213 |
| **Liabilities and stockholders' equity** |  |  |
| Accounts payable | $1059 | $3752 |
| Accrued expenses and other liabilities | 9070 | 11046 |
| Borrowings under line of credit | 15000 | 15000 |
| Current portion of long-term debt, net of original issue discount and debt issuance costs | 551 | 549 |
| Lease liabilities, current | 800 | 1549 |
| Settlement liabilities | 33882 | 21680 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 60362 | 53576 |
| Lease liabilities, non-current |  | 802 |
| Other liabilities | 1204 | 153 |
| Long-term debt, net of original issue discount and debt issuance costs | 51434 | 52067 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 113000 | 106598 |
| Commitments and contingencies (Note 12) |  |  |
| **Stockholders' equity:** |  |  |
| Preferred stock, par value $0.0001; 10,000,000 shares of preferred stock authorized as of December 31, 2022 and 2021, respectively; no shares of preferred stock issued and outstanding as of December 31, 2022 and 2021  |  |  |
| Common stock, par value $0.0001; 1,000,000,000 shares of Class A common stock authorized as of December 31, 2022 and 2021; 68,238,245 and 67,844,060 shares of Class A common stock issued and outstanding as of December 31, 2022 and 2021, respectively; 24,997,561 and 25,000,000 shares of LT10 common stock authorized as of December 31, 2022 and 2021, respectively; 7,336,191 and 7,332,640 shares of LT10 common stock issued and outstanding as of December 31, 2022 and 2021, respectively; 24,999,020 and 25,000,000 shares of LT50 common stock authorized as of December 31, 2022 and 2021, respectively; 6,854,931 and 6,224,160 shares of LT50 common stock issued and outstanding as of December 31, 2022 and 2021, respectively | 7 | 6 |
| Additional paid-in capital | 194807 | 142515 |
| Accumulated deficit | (97573) | (65906) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 97241 | 76615 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $210241 | $183213 |

---

------

**Expensify, Inc.**

**Consolidated Statements of Operations**

(unaudited, in thousands, except share and per share data)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Revenue | $43469 | $40364 | $169495 | $142835 |
| Cost of revenue, net<sup>(1)</sup> | 16105 | 19925 | 62669 | 53693 |
| Gross margin | 27364 | 20439 | 106826 | 89142 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development<sup>(1)</sup> | 2991 | 2850 | 13692 | 10988 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative<sup>(1)</sup> | 13155 | 24915 | 58490 | 60742 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing<sup>(1)</sup> | 11918 | 13109 | 49876 | 27664 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 28064 | 40874 | 122058 | 99394 |
| (Loss) income from operations | (700) | (20435) | (15232) | (10252) |
| Interest and other expenses, net | (185) | (920) | (5411) | (3480) |
| (Loss) income before income taxes | (885) | (21355) | (20643) | (13732) |
| (Provision for) benefit from income taxes | (2512) | (532) | (6366) | 174 |
| Net loss attributable to Class A, LT10 and LT50 common stockholders | $(3397) | $(21887) | $(27009) | $(13558) |
| Net loss per share attributable to Class A, LT10 and LT50 common stockholders: |  |  |  |  |
| Basic | $(0.04) | $(0.82) | $(0.33) | $(0.36) |
| Diluted | $(0.04) | $(0.82) | $(0.33) | $(0.36) |
| Weighted-average shares of common stock used to compute net (loss) income per share attributable to Class A, LT10 and LT50 common stockholders: |  |  |  |  |
| Basic | 81567647 | 26776561 | 80786725 | 38039222 |
| Diluted | 81567647 | 26776561 | 80786725 | 38039222 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Includes stock-based compensation expense as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Cost of revenue, net | $4125 | $3445 | $18403 | $4115 |
| Research and development | 1645 | 1135 | 7875 | 1617 |
| General and administrative | 2787 | 6238 | 17850 | 7356 |
| Sales and marketing | 1982 | 1261 | 8204 | 1486 |
| Total stock-based compensation expense | $10539 | $12079 | $52332 | $14574 |

---

------

**Expensify, Inc.**

**Consolidated Statements of Cash Flows**

(unaudited, in thousands)

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| | **2022** | **2021** | **2020** |
| Cash flows from operating activities: |  |  |  |
| Net loss | $(27009) | $(13558) | $(1710) |
| Adjustments to reconcile net loss to cash provided by operating activities: |  |  |  |
| Depreciation and amortization | 5388 | 5197 | 3248 |
| Reduction of operating lease right-of-use assets | 666 | 741 | 1311 |
| Loss on impairment, receivables and sale or disposal of equipment | 881 | 319 | 162 |
| Stock-based compensation | 52332 | 14574 | 17837 |
| Amortization of original issue discount and debt issuance costs | 42 | 32 | 32 |
| Deferred tax assets | 26 | 48 | 2437 |
| Deferred tax liabilities |  | (916) | 916 |
| Changes in assets and liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | (1341) | (6006) | (2170) |
| &nbsp;&nbsp;&nbsp;Settlement assets, net | (7796) | 173 | 2878 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses | (1389) | (6509) | 270 |
| &nbsp;&nbsp;&nbsp;Related party loan receivable | 14 | 586 |  |
| &nbsp;&nbsp;&nbsp;Other current assets | 2875 | (4100) | (1393) |
| &nbsp;&nbsp;&nbsp;Other assets | (81) | 124 | (248) |
| &nbsp;&nbsp;&nbsp;Accounts payable | (2693) | 1424 | (714) |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | (1537) | 7511 | 1774 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | (758) | (801) | (1374) |
| &nbsp;&nbsp;&nbsp;Settlement liabilities | 12202 | 7372 | (16548) |
| &nbsp;&nbsp;&nbsp;Other liabilities | 1054 | (725) | 877 |
| Net cash provided by operating activities | 32876 | 5486 | 7585 |
| Cash flows from investing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (585) | (2706) | (2488) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale or disposal of property and equipment | 5 |  | 2 |
| &nbsp;&nbsp;&nbsp;Software development costs | (1619) | (4908) | (1809) |
| Net cash used in investing activities | (2199) | (7614) | (4295) |
| Cash flows from financing activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Principal payments of finance leases | (793) | (774) | (808) |
| &nbsp;&nbsp;&nbsp;Principal payments of term loan | (595) | (25191) | (319) |
| &nbsp;&nbsp;&nbsp;Proceeds from term loan |  | 45000 |  |
| &nbsp;&nbsp;&nbsp;Principal payments of line of credit |  |  | (1000) |
| &nbsp;&nbsp;&nbsp;Proceeds from line of credit |  |  | 9613 |
| &nbsp;&nbsp;&nbsp;Vesting of restricted common stock |  | 567 |  |
| &nbsp;&nbsp;&nbsp;Proceeds from initial public offering, net of underwriters' discounts, commissions and offering costs |  | 57458 |  |
| &nbsp;&nbsp;&nbsp;Repurchases of early exercises of common stock | (25) |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from common stock purchased under Matching Plan | 3672 |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock on exercise of stock options | 795 | 3505 | 1301 |
| &nbsp;&nbsp;&nbsp;Payments for employee taxes withheld from stock-based awards | (5335) |  |  |
| &nbsp;&nbsp;&nbsp;Repurchase and retirement of common stock | (6000) |  |  |
| Net cash (used in) provided by financing activities | (8281) | 80565 | 8787 |
| Net increase in cash and cash equivalents and restricted cash | 22396 | 78437 | 12077 |
| Cash and cash equivalents and restricted cash, beginning of period | 125315 | 46878 | 34801 |
| Cash and cash equivalents and restricted cash, end of period | $147711 | $125315 | $46878 |
| Supplemental disclosure of cash flow information: |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | $3912 | $3082 | $2929 |
| &nbsp;&nbsp;&nbsp;Cash paid for income taxes | $975 | $6922 | $150 |
| Noncash investing and financing items: |  |  |  |
| &nbsp;&nbsp;&nbsp;Right-of-use assets acquired with lease liabilities | $— | $— | $1260 |
| Reconciliation of cash and cash equivalents and restricted cash to the Consolidated Balance Sheets: |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $103787 | $98398 | $34401 |
| &nbsp;&nbsp;&nbsp;Restricted cash included in other current assets | 19542 | 8651 | 1955 |
| &nbsp;&nbsp;&nbsp;Restricted cash included in other assets |  | 47 | 48 |
| &nbsp;&nbsp;&nbsp;Restricted cash included in settlement assets, net | 24381 | 18219 | 10474 |
| Total cash and cash equivalents and restricted cash | $147710 | $125315 | $46878 |

---

------

**Expensify, Inc.**

**Reconciliation of GAAP to Non-GAAP Financial Measures**

(unaudited, in thousands, except percentages)

*Adjusted EBITDA*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Net (loss) income | $(3397) | $(21887) | $(27009) | $(13558) |
| Add: |  |  |  |  |
| Provision for income taxes | 2512 | 532 | 6366 | (174) |
| Interest and other expenses, net | 185 | 920 | 5411 | 3480 |
| Depreciation and amortization | 1316 | 1465 | 5388 | 5197 |
| Stock-based compensation | 10539 | 12079 | 52332 | 14574 |
| Adjusted EBITDA | $11155 | $(6891) | $42488 | $9519 |

---

*Adjusted EBITDA Excluding the IPO-Related Bonus*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Net (loss) income | $(3397) | $(21887) | $(27009) | $(13558) |
| Add: |  |  |  |  |
| Provision for income taxes | 2512 | 532 | 6366 | (174) |
| Interest and other expenses, net | 185 | 920 | 5411 | 3480 |
| Depreciation and amortization | 1316 | 1465 | 5388 | 5197 |
| Stock-based compensation | 10539 | 12079 | 52332 | 14574 |
| IPO-related bonus expense |  | 14191 |  | 48416 |
| Adjusted EBITDA *Excluding the IPO-Related Bonus* | $11155 | $7300 | $42488 | $57935 |

---

------

**Expensify, Inc.**

**Reconciliation of GAAP to Non-GAAP Financial Measures**

(unaudited, in thousands, except percentages)

*Non-GAAP Net Income and Non-GAAP Net Income Margin*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Net (loss) income | $(3397) | $(21887) | $(27009) | $(13558) |
| Net (loss) income margin | (8)% | (54)% | (16)% | (9)% |
| Add: |  |  |  |  |
| Stock-based compensation | 10539 | 12079 | 52332 | 14574 |
| IPO-related bonus expense |  | 14191 |  | 48416 |
| Non-GAAP net income | $7142 | $4383 | $25323 | $49432 |
| Non-GAAP net income margin | 16% | 11% | 15% | 35% |

---

*Adjusted Operating Cash Flow and Free Cash Flow*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Net cash (used in) provided by operating activities | $6647 | $(29094) | $32876 | $5486 |
| Operating cash flow margin | 15% | (72)% | 19% | 4% |
| (Increase) decrease in changes in assets and liabilities: |  |  |  |  |
| &nbsp;&nbsp;Settlement assets | (2300) | (3517) | 7796 | (173) |
| &nbsp;&nbsp;Settlement liabilities | 2501 | 3327 | (12202) | (7372) |
| Adjusted operating cash flow | $6848 | $(29284) | $28470 | $(2059) |
| Less: |  |  |  |  |
| &nbsp;&nbsp;Purchases of property and equipment | (118) | (104) | (585) | (2706) |
| &nbsp;&nbsp;Software development costs | (713) | (511) | (1619) | (4908) |
| Free cash flow | $6017 | $(29899) | $26266 | $(9673) |
| Free cash flow margin | 14% | (69)% | 15% | (5)% |

---

## Exhibit 99.2

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide1.jpg](slide1.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide2.jpg](slide2.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide3.jpg](slide3.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide4.jpg](slide4.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide5.jpg](slide5.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide8.jpg](slide8.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide9.jpg](slide9.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide81.jpg](slide81.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide111.jpg](slide111.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide10.jpg](slide10.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide11.jpg](slide11.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide12.jpg](slide12.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide13.jpg](slide13.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide171.jpg](slide171.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide15.jpg](slide15.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide16.jpg](slide16.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide17.jpg](slide17.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide18.jpg](slide18.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide19.jpg](slide19.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide20.jpg](slide20.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide21.jpg](slide21.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide251.jpg](slide251.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide26.jpg](slide26.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide271.jpg](slide271.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide25.jpg](slide25.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide261.jpg](slide261.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide27.jpg](slide27.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide28.jpg](slide28.jpg)

------

**Exhibit 99.2**

**Expensify, Inc.**

**Investor Presentation**

![slide26.jpg](slide26.jpg)